Drug Shortage Report for OXYTROL
Report ID | 62335 |
Drug Identification Number | 02254735 |
Brand name | OXYTROL |
Common or Proper name | Oxytrol |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OXYBUTYNIN |
Strength(s) | 36MG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL |
Packaging size | 8 patches |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-09-10 |
Actual start date | 2018-09-10 |
Estimated end date | 2018-10-26 |
Actual end date | 2018-11-02 |
Shortage status | Resolved |
Updated date | 2018-11-03 |
Company comments | Production delay |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-09-25 | English | Compare |
v2 | 2018-09-25 | French | Compare |
v3 | 2018-11-02 | English | Compare |
v4 | 2018-11-02 | French | Compare |
v5 | 2018-11-03 | English | Compare |
Showing 1 to 5 of 5